Risk stratification of endometrial cancer and lymph node metastases prediction using 18F-FDG PET/CT: role of metabolic tumor volume and total lesion glycolysis

Egyptian Journal of Radiology and Nuclear Medicine

Table 1 Histopathological characteristics of EC

Histological characteristic	Number of cases (%)
Histopathological type
Non-endometrioid	5/33 (15.2%)
Endometrioid	28/33 (84.8%)
Histopathological grade
G 1	15/33 (45.5%)
G 2	11/33 (33.3%)
G 3	7/33 (21.2%)
FIGO stage
IA	15/33 (45.5%)
IB	6/33 (18.2%)
II	2/33 (6.1%)
IIIB	1/33 (3%)
IIIC	7/33 (21.2%)
IVB	2/33 (6%)
Myometrial invasion
< 50%	15/33 (45.5%)
> 50%	18/33 (54.5%)
LVSI
Yes	15/33 (45.5%)
No	18/33 (54.5%)
LNMs
Yes	9/33 (27.3%)
No	24/33 (72.7%)
Risk stratification
Low risk	11/33 (33.3%)
High risk	22/33 (66.7%)